HOME >> BIOLOGY >> NEWS
Multiple-drug resistant gene expression pattern predicts treatment outcome for pediatric leukemia

A new study is providing scientists with a better understanding of why some pediatric acute lymphoblastic leukemia (ALL) patients fail to respond to treatment even when existing clinical predictive criteria point towards a positive treatment outcome. The research, published in the April issue of Cancer Cell, is likely to facilitate development of new strategies to combat drug resistance and treatment failure for children with ALL.

Nearly 80% of children with ALL are cured following chemotherapeutic treatment. However, the remaining 20% often exhibit drug resistance and treatment failure that is poorly understood. In some cases, patients are resistant to multiple drugs that have very little structural similarity, suggesting that the mechanisms for drug cross-resistance are probably not the same as mechanisms underlying resistance to a single drug. Dr. William E. Evans from St. Jude Children's Research Hospital and colleagues used a comprehensive genetic screening technique to search for genes that are differentially expressed in ALL cells that demonstrated cross-resistance to two or more commonly used chemotherapeutic agents.

The researchers identified several genes that were differentially expressed in ALL cells that exhibited de novo cross resistance to four widely used antileukemic agents. They went on to investigate the relationship of these genes to treatment outcome in ALL patients and found that expression of the genes was associated with treatment outcome and could be used to identify a subset of patients with a markedly inferior response to treatment. In addition, the findings revealed a previously unrecognized phenotype characterized by discordant resistance to two widely used and mechanistically distinct antileukemic agents and provided new information about the cellular mechanisms involved in disparate response to these drugs.

Specific genetic signatures related to ALL treatment failure and chemotherapeutic cross-resistance w
'"/>

Contact: Heidi Hardman
hhardman@cell.com
1-617-397-2879
Cell Press
18-Apr-2005


Page: 1 2

Related biology news :

1. Pets could be source of multiresistant bacteria infections in humans, MU researchers investigate
2. New way to target and kill antibiotic-resistant bacteria found
3. First all-African produced genetically engineered maize is resistant to maize streak virus
4. Malaria-resistant mosquitoes battle disease with molecular warhead
5. Wellcome Trust and GlaxoSmithKline announce partnership to target drug-resistant hospital infections
6. Arming the fight against resistant bacteria
7. Researchers uncover protection mechanism of radiation-resistant bacterium
8. Will the plague pathogen become resistant to antibiotics?
9. Trojan horse strategy defeats drug-resistant bacteria
10. Breakthrough vaccine to treat chemo-resistant ovarian cancer
11. Protein discovery targets antibiotic-resistant bacteria

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/8/2019)... Denmark and RALEIGH, N.C. (PRWEB) , ... January ... ... in micro acoustic and micro mechanical technologies and solutions for hearing instruments and ... technology, today announced BiometRIC, the first ever hearing aid receiver in canal with ...
(Date:1/4/2019)... ... January 03, 2019 , ... ... culture models into their drug discovery research workflows with biology ranging from single ... vivo relevancy of in vitro studies, they create several challenges that need to ...
(Date:12/22/2018)... , ... December 21, 2018 , ... ... sponsored and hosted the Boston Healthcare Drinks event featuring Helen Chen, Greater China ... from China.” , The discussion was moderated by patent attorney David J. ...
Breaking Biology News(10 mins):
(Date:1/15/2019)... (PRWEB) , ... January 15, 2019 , ... With the U.S. Congress designating January as ... transmitted disease (STD) testing service, today announces tips to help reduce the risk of Cervical ... Human Papillomavirus (HPV). Genital HPV is the #1 most common STD and an ...
(Date:1/10/2019)... ... January 08, 2019 , ... Rascal was adopted from a local shelter when he was ... mixed breed.” Unfortunately, just six weeks after he was adopted, he tore his right ... to form in the joint after such a traumatic injury. , Sure enough, when Rascal ...
(Date:1/8/2019)... ... January 07, 2019 , ... ... members into Noninvasix. This represents the second investment AngelMD has made into Noninvasix ... morbidity, Noninvasix is developing a patient monitor to directly, accurately, and noninvasively measure ...
(Date:1/4/2019)... ... January 04, 2019 , ... Triangle Insights ... to the firm. Ted will be joining the firm as a partner. ... consulting services to the pharmaceutical industry. At Triangle Insights, Ted will apply his ...
Breaking Biology Technology:
Cached News: